Bruin Biometrics
Bruin Biometrics: Developing FDA-approved wireless health devices to address unmet medical needs.
Founded
2009Bruin Biometrics: Developing FDA-approved wireless health devices to address unmet medical needs.
Founded in 2009, Bruin Biometrics, LLC (BBI) is a multi-member partnership based in Los Angeles, United States. The company’s core mission is to develop a robust portfolio of patent-protected, FDA-approved wireless health devices that address significant medical conditions and unmet medical needs. BBI’s flagship product is the Sub-Epidermal Moisture (SEM) Scanner Device, designed to detect pressure ulcers early. The company focuses on leveraging advanced wireless health technologies licensed exclusively from the UCLA Wireless Health Institute.
Bruin Biometrics has garnered attention for its innovative approach to healthcare technology. The company is affiliated with notable institutions and has secured investments to support its mission. Key achievements include the development and FDA approval of the SEM Scanner Device, which has had a significant impact on improving patient outcomes by enabling early detection of pressure ulcers. BBI continues to influence the healthcare industry by addressing critical gaps with its cutting-edge wireless health solutions.
Companies similar to Bruin Biometrics include MediSens, Bionet Sonar, BioscanR and Aulisa.
Bruin Biometrics was founded in 2009.
Bruin Biometrics' headquarters is located in Los Angeles, CA, US.
Bruin Biometrics' most recent funding round was for $1.4M (USD) in December 2018.
As of Dec 7, 2018, Bruin Biometrics has disclosed funding of $20.4M (USD). Undisclosed round amounts are excluded.
Bruin Biometrics has 23 employees as of Feb 4, 2024.
aulisa.com
